A 45-year-old man with dermatomal vesicular rash and severe pain on the right thorax is diagnosed with herpes zoster. He presents on day 4 of illness. What is the drug of choice for treatment?

Question

Accepted Answer

A. Valacyclovir. ## First-Line Antiviral for Herpes Zoster (Shingles)

**Key Point:** Valacyclovir is the preferred first-line antiviral for herpes zoster (VZV) in immunocompetent adults due to superior oral bioavailability, less frequent dosing, and equivalent efficacy to intravenous acyclovir.

### Rationale for Valacyclovir Over Acyclovir

**High-Yield:** For zoster, valacyclovir is preferred because:
1. **Oral bioavailability:** 54% vs acyclovir's 15–20%
2. **Dosing convenience:** 1000 mg three times daily vs acyclovir 800 mg five times daily
3. **Equivalent efficacy to IV acyclovir:** Achieves serum levels comparable to IV acyclovir
4. **Reduces postherpetic neuralgia (PHN)** when started within 72 hours
5. **Reduces viral dissemination and complications**

### Treatment Algorithm for Herpes Zoster

```mermaid
flowchart TD
  A[Herpes Zoster Diagnosis]:::outcome --> B{Immunocompetent?}:::decision
  B -->|Yes| C{Within 72 hours?}:::decision
  B -->|No| D[IV Acyclovir 10-15 mg/kg/8h]:::action
  C -->|Yes| E[Valacyclovir 1000 mg TID × 7 days]:::action
  C -->|No| F[Consider treatment if severe pain/complications]:::action
  E --> G[Reduces PHN, viral dissemination]:::outcome
  D --> H[Immunocompromised protection]:::outcome
```

### Comparative Dosing and Efficacy

| Drug | Indication | Dosage | Bioavailability | Advantage | Limitation |
|------|-----------|--------|-----------------|-----------|------------|
| **Valacyclovir** | Zoster (immunocompetent) | 1000 mg TID × 7 days | 54% | First-line; convenient dosing | Cost |
| **Acyclovir** | Zoster (if valacyclovir unavailable) | 800 mg 5× daily × 7 days | 15–20% | Cheap; long experience | Frequent dosing; lower bioavailability |
| **Famciclovir** | Alternative for zoster | 500 mg TID × 7 days | 77% | Excellent bioavailability | Less data than valacyclovir in zoster |
| **IV Acyclovir** | Zoster (immunocompromised) | 10–15 mg/kg IV 8-hourly | 100% (IV) | Essential for severe/disseminated | Requires hospitalization; nephrotoxicity risk |

### Timing and Efficacy

**Clinical Pearl:** Antiviral therapy is most effective when started within **72 hours (3 days)** of rash onset. This patient presented on day 4, which is slightly beyond the ideal window, but treatment may still be considered if pain is severe or complications are present.

**Warning:** Do NOT use acyclovir as first-line for zoster in immunocompetent adults — its poor oral bioavailability (15–20%) makes it suboptimal compared to valacyclovir or famciclovir.

### Additional Measures
- Analgesics (NSAIDs, paracetamol, gabapentin for neuropathic pain)
- Topical capsaicin or lidocaine patches
- Consider tricyclic antidepressants (amitriptyline) if PHN develops

Answer

B. Ganciclovir

Answer

C. Acyclovir

Answer

D. Penciclovir

A 45-year-old man with dermatomal vesicular rash and severe pain on the right thorax is diagnosed with herpes zoster. He presents on day 4 of illness. What is the drug of choice for treatment?

Explanation

First-Line Antiviral for Herpes Zoster (Shingles)

Rationale for Valacyclovir Over Acyclovir

Treatment Algorithm for Herpes Zoster

Comparative Dosing and Efficacy

Timing and Efficacy

Additional Measures

Practice similar questions

Join our NEET PG community

Drug	Indication	Dosage	Bioavailability	Advantage	Limitation
Valacyclovir	Zoster (immunocompetent)	1000 mg TID × 7 days	54%	First-line; convenient dosing	Cost
Acyclovir	Zoster (if valacyclovir unavailable)	800 mg 5× daily × 7 days	15–20%	Cheap; long experience	Frequent dosing; lower bioavailability
Famciclovir	Alternative for zoster	500 mg TID × 7 days	77%	Excellent bioavailability	Less data than valacyclovir in zoster
IV Acyclovir	Zoster (immunocompromised)	10–15 mg/kg IV 8-hourly	100% (IV)	Essential for severe/disseminated	Requires hospitalization; nephrotoxicity risk